Fredun Pharmaceuticals Ltd

NSE: FREDUN · BSE: 539730 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹1,520.20
Market cap: ₹2,172 Cr
Revenue (annual): ₹635.5 Cr
Net profit (annual): ₹32.62 Cr
P/E (TTM): 49.6×Sector 47.4×
Promoter holding: 44.57%+0.40% QoQ
FII holding: 1.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 5 Financial Results 4 Other Announcement 3 Earnings Call 3 Results Update 2 Bonus Issue 2 Annual General Meeting 2 Acquisition 2 Product Launch 1 Dividend 1 Debt & Borrowing 1 Capacity Expansion 1 Business Update 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

31 announcements with these filters

6 Apr 2026 17:35 IST BSE

Other Announcement

Fredun Pharmaceuticals Other Announcement

Fredun Pharmaceuticals Ltd submitted its quarterly compliance certificate under Regulation 74(5) for the period ended March 31, 2026. The report confirms that 1,000 shares belonging to Nikhil Vora and Sheela Vora were dematerialised during the quarter. This is a routine regulatory filing with no material impact on business operations.

Read the filing ↗